Multicenter phase ii study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG)

BACKGROUND: Improvement of current GVHD prophylactic therapies remains an important goal in the allo-HSCT. We have described a novel prophylaxis regimen in a single institution trial. The Chinese Bone Marrow Transplant Cooperative Group (CBMTCG) initiated a phase II multicenter study. METHODS: The s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Hematol Oncol
Autors principals: Lai, Yong-rong, Chen, Yu-hong, Hu, Deng-ming, Jiang, Ming, Liu, Qi-fa, Liu, Lin, Hou, Jian, Schwarzenberger, Paul, Li, Qiao-chuan, Zhang, Zhong-ming, Liu, Kai-yan, Huang, Xiao-jun
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4237802/
https://ncbi.nlm.nih.gov/pubmed/25139202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-014-0059-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars